Critical care medicines play a vital role in reducing morbidity and mortality. In addition, critical care patients have life-threatening conditions requiring healthcare professionals to often use a multi-pronged treatment
| Products | ||
|---|---|---|
| 1 | EVEROLIMUS | 5 mg /10 mg tablet |
| 2 | METHOTREXATE | 2.5 / 7.5 / 15 mg |
| 3 | AMOXICILLIN SODIUM (Dry powder injection) | 250/5000/1000 mg |
| 4 | AMOXICILLIN SODIUM + CLOXACILLIN SODIUM (Dry powder injection) | 250/500/1000 mg + 250/500/1000 mg |
| 5 | AMPICILLIN SODIUM + SULBACTUM SODIUM (Dry powder injection) | 500/1000 MG + 250 /500 MG |
| 6 | AMPICILLIN SODIUM + CLOXACILLIN SODIUM (Dry powder injection) | 250/500/1000 MG + 250/500/1000 MG |
| 7 | CEFAZOLIN SODIUM (Dry powder injection) | 500/1000 MG |
| 8 | CEFOPERAZONE SODIUM+ TAZOBACTAM (Dry powder injection) | 500/ 1000 MG + 62.5/125 MG |
| 9 | CEFOPERAZONE SODIUM + SULBACTUM SODIUM (Dry powder injection) | |
| 10 | IMIPENEM + CILASTATIN (Dry powder injection) | 250/500 MG +250/500 MG |
| 11 | MEROPENEM (Dry powder injection) | 125/ 250/500/1000 MG |
| 12 | MEROPENEM + SULBACTAM (Dry powder injection) | 1000MG+125 MG |
| 13 | MEROPENEM + TAZOBACTAM Dry powder injection) | 1000MG+125 MG |
| 14 | PIPERACILLIN + TAZOBACTAM (Dry powder injection) | 4000MG+500 MG |
English
French
German
Spanish